← Leaderboards
Mary A. Lokuta
Stratatech Corporation
$3,821,515
Attributed
$5,952,410
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–13$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,952,410 · 2
By mechanism
R44$5,952,410 · 2
Top collaborators
- Allen R. Comer3 shared
Most similar at Stratatech Corporation
Same institution · by research overlap
- Allen R. Comer$10,946,387
- Allen R Comer$2,615,363
- John M Centanni$2,752,711
- Barbara Lynn Allen-Hoffmann$2,350,666
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertySkin TissueKeratinocytePre-ClinicalQualifyingSkin SubstitutesExhibitsHealingModificationPathogenDesignDiagnosisSafetySkinClinical ResearchBiologicalGeneticHealedClinical TrialsLifeCell BankCell LineCellsSmall Business Innovation Research Grant
Grant awards (7)
Clinical Trial of Antimicrobial Skin to treat Diabetic Ulcers$1,049,455
R44 · FY2013 · DK · contact PI
Clinical Trial of Antimicrobial Skin to treat Diabetic Ulcers$1,931,207
R44 · FY2012 · DK · contact PI
A Clinical Trial of Antimicrobial Skin Substitutes for Treatment of Diabetic Ulce$1,281,128
R44 · FY2011 · DK · contact PI
Tissue-Based Cytokine Immunotherapy for Skin Cancer$841,868
R44 · FY2011 · CA · contact PI
Tissue-Based Cytokine Immunotherapy for Skin Cancer$214,392
R44 · FY2011 · CA · contact PI
Tissue-Based Cytokine Immunotherapy for Skin Cancer$423,965
R44 · FY2010 · CA · contact PI
Tissue-Based Cytokine Immunotherapy for Skin Cancer$210,395
R44 · FY2009 · CA · contact PI